Company / R&D Expense
Steris R&D Expense History
FY2018-FY2026 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D Expense
$103.7M
FY2026
5-year range
$65.5M / $107.6M
FY2022-FY2026
Trend
+5.3%
vs FY2025
Sector context
#53 of 110
Health Care
What the data says
At $104M, Steris's r&d expense ranks #53 of 110 in the Health Care sector. R&D Expense has fluctuated over the past 9 years, ranging from $59M in FY2019 to $108M in FY2024.
Based on SEC 10-K filings.
$104M in FY2026 with a 5-year CAGR of +10.5%.
Declined from $108M to $104M over the past 2 years.
Health Care sector context is included.
R&D Expense over time
Growth rates
- 3-Year CAGR
- +0.0%
- 5-Year CAGR
- +10.5%
- 10-Year CAGR
- -
Sector benchmark
#53 of 110 in Health CareTop 48% of 110This company $103.7M Sector average $298.2M
▼
-65.2% below sector average
Key checks
Key Insights
- 5-year CAGR of +10.5%, indicating consistent growth.
- In FY2026, r&d expense increased 5.3% year-over-year.
- Ranks #53 out of 110 companies in the Health Care sector.
- Peak r&d expense was recorded in FY2024.
Annual data
| Year | R&D ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2026 | $103.7M | +5.3% |
| FY2025 | $98.5M | -8.5% |
| FY2024 | $107.6M | +3.8% |
| FY2023 | $103.7M | +58.2% |
| FY2022 | $65.5M | +4.0% |
| FY2021 | $63.0M | -5.0% |
| FY2020 | $66.3M | +11.7% |
| FY2019 | $59.4M | -5.8% |
| FY2018 | $63.0M | - |
| FY2017 | - | - |
As of FY2026 · SEC 10-K · Updated Jun 30, 2026